Interleukin-10 promoter polymorphisms are associated with the mode and sequel of HBeAg seroconversion in patients with chronic hepatitis B virus infection

Liver International

Volumn 26, Issue 3, 2006, Pages 326-333

  Peng, Xiao Mou ^a   Huang, Yang Su ^a   Ma, Hui Hui ^a   Gu, Lin ^a   Xie, Qi Feng ^a   Gao, Zhi Liang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Genotype; Haplotype; HepatitisB virus; Interleukin; Polymorphism

Indexed keywords

CARRIER PROTEIN; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 10;

ADULT; ARTICLE; CHINA; CHRONIC HEPATITIS; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; SEQUENCE ANALYSIS; SEROCONVERSION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CHINA; DNA PRIMERS; DNA, VIRAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA;

EID: 33644791906     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01241.x     Document Type: Article

References (27)

1. Ganem D, Prince A M. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004; 350: 111-29.
2. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003; 23: 47-58.
3. Liu C J, Kao J H, Lai M Y, Chen P J, Chen D S. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis. J Med Virol 2004; 72: 545-50.
4. Thursz M. Genetic susceptibility in chronic viral hepatitis. Antiviral Res 2001; 52: 113-6.
5. Hamada H, Yatsuhashi H, Yano K, Arisawa K, Nakao K, Yano M. Interleukin-10 promoter polymorphisms and liver fibrosis progression in patients with chronic hepatitis C in Japan. J Hepatol 2003; 39: 457-8.
6. Wang F.S. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003; 9: 641-4.
7. Hohler T, Kruger A, Gerken G, Schneider P M, Meyer Zum Buschenefelde K H, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998; 111: 579-82.
8. Ben-ari Z, Mor E, Papo O, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003; 98: 144-50.
9. Chisari F V, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60.
10. Rehermann B, Lau D, Hoofnagle J H, Chisari F V. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 1996; 97: 1655-65.
11. Guidotti L G, Ishikawa T, Hobbs M V, Matzke B, Schreiber R, Chisari F V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 25-36.
12. Pontesilli O, Van Nunen A B, Van Riel D, et al. Hepatitis B virus-specific T cell response in chronic hepatitis B patients treated with lamivudine and interferon-alpha. Liver Int 2004; 24: 308-15.
13. Moore K.W. O'garra A. De Waal Malefyt R. Vieira P. Mosmann T.R. Interleukin-10. Annu Rev Immunol 1993; 11: 165-90.
14. Turner D M, Williams D M, Sankaran D, Lazarus M, Sinnott P J, Hutchinson I V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
15. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors - a twin study. Genes Immun 2002; 3: 407-13.
16. Westendorp R G, Langermans J A, Huizinga T W, Verweij C L, Sturk A. Genetic influence on cytokine production in meningococcal disease. Lancet 1997; 349: 1912-3.
17. Miyazoe S, Hamasaki K, Nakata K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 2002; 97: 2086-92.
18. Evans A A, Fine M, London W T. Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: Implications for interferon therapy. J Infect Dis 1997; 176: 845-50.
19. Peng X M, Gu L, Huang Y S, et al. Simultaneous detection of two major lamivudine-resistant mutants using competitively differentiated-PCR. J Virol Methods 2005; 128: 168-75.
20. Bozkaya H, Bozdayi M, Turkyilmaz R, et al. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: Their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology 2000; 47: 1675-9.
21. Peng X M, Chen X J, Li J G, Huang Y S, Gao Z L. Novel Assay of Competitively Differentiated Polymerase Chain Reaction for Screening Point Mutation of Hepatitis B Virus. World J Gastroenterol 2003; 9: 1743-46.
22. Girndt M. Humoral immune responses in uremia and the role of IL-10. Blood Purif 2002; 20: 485-8.
23. Girndt M, Sester U, Sester M, et al. The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. Kidney Int 2001; 60: 2385-91.
24. Knapp S, Hennig B J, Frodsham A J, et al. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 2003; 55: 362-9.
25. Shin H D, Park B L, Kim L H, et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 2003; 12: 901-6.
26. Daly L M, Johnson P A, Donnelly G, Nicolson C, Robertson J, Mills K H. Innate IL-10 promotes the induction of Th2 responses with plasmid DNA expressing HIV gp120. Vaccine 2005; 23: 963-74.
27. Jarrosson L, Kolopp-Sarda M N, Aguilar P, et al. Most humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responses. Vaccine 2004; 22: 3789-96.